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ORIGINAL ARTICLE
Continuous curvilinear capsulorhexis (CCC) is a
critical step in phacoemulsification for decreasing
the risk of capsule tearing and allowing safe ma-
nipulation of the lens.1,2 In eyes with an advanced
(mature or hypermature) cataract, CCC is diffi-
cult to perform because of the absence of the red
reflex and poor visibility of the anterior capsule.3,4
Uncertain continuity of the capsulorhexis margin,
together with emulsification of a hard nucleus,
may lead to various intraoperative complications
such as radial tear, zonular dehiscence, posterior
capsule rupture, vitreous loss, nucleus drop, and
intraocular lens (IOL) displacement. When surgery
for advanced cataracts is additionally complicated
by the presence of anterior segment abnormali-
ties (such as corneal opacity caused by macular
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cornea, advanced pterygium, band keratopathy,
or previous corneal grafting; small pupils caused
by inadequate mydriasis, pupil synechia, or pupil
occlusion; or glaucoma), capsulorhexis and the
rest of the phacoemulsification procedure will be
even more difficult and carry a higher risk of
complications.
A number of studies have shown that staining
of the anterior capsule with dye, such as indo-
cyanine green (ICG) or trypan blue (TB), helps
to visualize the capsular margin during capsu-
lorhexis of a mature/hypermature cataract.5–20 We
are unsure if a dye-enhanced technique would
also be helpful during phacoemulsification of ad-
vanced cataracts complicated by various anterior
segment abnormalities. Therefore, we investi-
gated the rate of intraoperative and postopera-
tive complications and effects on visual acuity of
ICG-assisted phacoemulsification in eyes with
advanced cataracts, with or without anterior seg-
ment abnormalities.
Methods
Patients
The patients were 35 individuals without con-
genital abnormalities of the eye or adnexa, active
uveitis, or retinal or choroidal detachment detected
by B-scan ultrasonography, who consecutively un-
derwent phacoemulsification of complicated or
simple advanced cataracts performed by the same
experienced surgeon (S.H.T.) at National Cheng
Kung University in Taiwan between September
2001 and August 2004. Informed consent was
obtained from all patients.
Advanced (mature/hypermature) cataract was
defined as total lens opacity and lack of a red re-
flex during capsulorhexis. Complicated or simple
cataract was defined as the presence or absence,
respectively, of a condition in the anterior seg-
ment that could complicate phacoemulsification.
Before capsulorhexis, ICG was used to stain the
anterior capsule in all patients.
Preoperatively, patients were divided into 
two groups (Table 1) based on the presence of a
complicating condition in the anterior segment.
Group 1 consisted of 15 patients (17 eyes) with
advanced (mature or hypermature) cataract and
at least one of the following conditions: corneal
opacity (causes included macular cornea, advanced
pterygium, band keratopathy, and previous corneal
grafting), small pupil (causes included inadequate
mydriasis, pupil synechia, and pupil occlusion),
and various types of glaucoma. Group 2 con-
sisted of 17 patients (18 eyes) with an advanced
cataract without any significant anterior segment
abnormality (Table 2).
Preoperative evaluation
Evaluations performed preoperatively included
measurement of best-corrected visual acuity, ker-
atometry, tonometry, axial length, slit-lamp exam-
ination to evaluate the severity of the cataract, and
B-scan ultrasonography to rule out posterior seg-
ment pathology in the eyes with opaque medium
that hindered fundoscopic examination.
Dye preparation5–9
Immediately before use, 25 mg ICG (Daiichi
Pharmaceutical, Tokyo, Japan) was dissolved in
0.5 mL aqueous solvent (provided with the ICG
Table 1. Characteristics of patients with advanced cataract with (group 1) or without (group 2) pre-existing
anterior segment abnormalities*
Patient characteristic Group 1 Group 2 p
Eye (patients) 17 (15) 18 (17)
Age (yr) 60.0 ± 13.6 (21–73) 69.4 ± 9.6 (50–84) 0.02
Gender (male:female) 8:9 5:13 0.31
Follow-up (mo) 10.4 ± 13.0 (0.4–42.5) 5.0 ± 7.4 (0.1–30.3) 0.13
*Data presented as mean ± standard deviation (range) or n.
compound). The solution was then mixed with
4.5 mL balanced salt solution (BSS plus®; Alcon,
Fort Worth, TX, USA). The final solution con-
tained 0.5% ICG and had an osmolarity of
∼270 mOsm/kg.
Surgical technique
Anesthesia was achieved by retrobulbar ganglion
block or combined topical/intracameral anesthe-
sia, depending on the patient’s ability to fixate on
the light of the operating microscope. Mydriasis
was achieved by instillation of three successive
drops, 5 minutes apart, of Mydrin®-P (0.5% tropi-
camide and 0.5% phenylephrine hydrochloride;
Santen Pharmaceutical Co., Ltd., Osaka, Japan).
In eyes with inadequate mydriasis (posterior
synechiae, seclusio or occlusio pupillae), a pupil
size adequate for the procedure was achieved by
synechiolysis and/or placement of an iris retractor
(Grieshaber, Switzerland).
A clear corneal incision was made and the
aqueous humor was replaced by air. A small
amount of the ophthalmic surgical device, Viscoat®
(4% sodium chondroitin sulfate/3% sodium
hyaluronate; Alcon, Belgium), was injected close
to the corneal wound to prevent leakage of air.
With a 26-gauge flat cannula, 0.1 mL 0.5% ICG
was instilled onto the anterior capsule. The air in
the anterior chamber allowed the formation of a
“dye lake” over the anterior capsule, bordered by
the pupillary margin; it also prevented dilution of
the dye by the aqueous humor, so that the lowest
effective concentration of ICG was achieved, as
described previously.21,22
After the dye had been in contact with the
capsule for approximately 30 seconds, Viscoat®
was injected into the anterior chamber to replace
the air. During capsulorhexis, good contrast was
seen between the greenish-stained anterior cap-
sule rim and the unstained underlying whitish
cortex, even in patients with abnormalities in the
anterior segment (Figure 1). The rest of the sur-
gical procedure, including phacoemulsification,
irrigation and aspiration of cortex, and IOL im-
plantation, proceeded routinely. Any intraopera-
tive findings or complications were recorded.
Postoperative follow-up
Patients were examined on postoperative days 1
and 3 and at 1 week, 1 month and 3 months
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Table 2. Preoperative ocular manifestations in 17 eyes of group 1
and 18 eyes of group 2*
Ocular manifestation Group 1† Group 2
Hypermature white cataract 10 (58.8) 18 (100.0)
Corneal opacity
Macular cornea 4 (23.5) 0 (0)
Small pterygium 0 (0) 3 (16.7)
Advanced pterygium 2 (11.8) 0 (0)
Band keratopathy 2 (11.8) 0 (0)
Corneal graft 1 (5.9) 0 (0)
Small pupil
Inadequate mydriasis 3 (17.6) 0 (0)
Pupil synechiae 1 (5.9) 0 (0)
Pupil occlusion 1 (5.9) 0 (0)
Glaucoma
Phacomorphic glaucoma 2 (11.8) 0 (0)
Phacolytic glaucoma/uveitis 2 (11.8) 0 (0)
Steroid glaucoma 2 (11.8) 0 (0)
Neovascular glaucoma 1 (5.9) 0 (0)
Primary open-angle glaucoma 
previously undergone trabeculectomy 1 (5.9) 0 (0)
*Data presented as n (%); †five patients in group 1 had a combination of corneal
opacity, small pupil, and glaucoma.
Figure 1. Intraoperative appearance of a complicated ad-
vanced cataract after synechiolysis and enlargement of the
constricted pupil with iris hooks (black arrow), followed by
staining with 0.5% indocyanine green (ICG) to distinguish
the anterior capsule (stained light green by ICG) from the
underlying white cortex. The scar (white arrow) and con-
stricted pupil were due to previous corneal grafting.
after surgery. At each follow-up visit, a complete
ophthalmic examination was performed, includ-
ing measurement of visual acuity, refraction,
tonometry, slit-lamp examination, and fundus
examination.
Statistical analysis
Data were analyzed using SAS version 9 (SAS
Institute Inc., Cary, NC, USA) for statistically sig-
nificant differences between groups 1 and 2 using
Student’s t test and Fisher’s exact test with the
level of significance set at p < 0.05.
Results
Table 3 summarizes the anesthetic method used
and the adjunctive surgical procedures performed
for each patient group. Phacolytic uveitis and ab-
solute glaucoma were diagnosed in one eye in
group 1, and thus no IOL was implanted in this
eye. The other 34 eyes (16 in group 1, 18 in
group 2) underwent routine phacoemulsification
and insertion of a foldable IOL using an injector.
A noticeable difference between the two groups
was that 30% of eyes in group 1 required addi-
tional papillary dilatation by iris hooks because
of inadequate mydriasis, or synechia or occlusion
of the pupil.
The intraoperative and postoperative compli-
cations are shown in Table 4. The only signifi-
cant difference between the two groups was the
occurrence of radial tears during the capsulorhexis
procedure in four eyes in group 1 (p < 0.05). It is
noteworthy that radial tears mainly occurred
when the lens was tumescent. In these cases, im-
mediately after the first small flap-tear of the an-
terior capsule had been created with a 25-gauge
cystotome needle (Visitec®; BD Ophthalmic Sys-
tems, Waltham, MA, USA), a gush of milky cor-
tex rushed out of the opening, followed by the
spontaneous occurrence of two radial tears that
extended from the center to the lens periphery
within a few seconds, because of high intralen-
ticular pressure (Figure 2A). We injected a large
bolus of Viscoat® adjacent to the tears to prevent
further extension, and then used Vannas scissors
to make cuts in the anterior capsule at the periph-
eral end of each tear to complete capsulorhexis,
which resulted in a circular flap with two radial
relaxing incisions (Figure 2B). In these four eyes,
phacoemulsification and irrigation and aspiration
of the cortex were performed with exceptional
caution, to avoid extension of the radial tears. In
three of these eyes, an IOL was implanted with-
out incident in the ciliary sulcus, with the axis of
haptics at 90 degrees to the radial tears; no IOL
was placed in the final eye, which was the one
ICG for advanced cataracts
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Table 3. Anesthetic and adjunct surgical procedures for
phacoemulsification of advanced cataract in 17 eyes 
with anterior segment abnormalities (group 1) and 
18 eyes without (group 2)*
Procedure Group 1 Group 2 p
Anesthesia (RBGB:T+IC) 7:10 7:11 1.00
Iris hooks to extend the pupil 5 (29.4) 0 (0) 0.02
Bare sclera 2 (11.8) 2 (11.1) 1.00
Calcium plaque removal 1 (5.9) 0 (0) 0.49
*Data presented as n or n (%). RBGB = retrobulbar ganglion block; T+IC = combined
topical and intracameral anesthesia.
Table 4. Intraoperative and postoperative complications of
phacoemulsification of advanced cataracts in 17 eyes 
with anterior segment abnormalities (group 1) and 
18 eyes without (group 2)*
Complication Group 1 Group 2 p
Intraoperative
Radial tear 4 (23.5) 0 (0) 0.046
Posterior capsule rupture 0 (0) 0 (0) –
Vitreous loss 0 (0) 0 (0) –
IOL displacement 0 (0) 0 (0) –
Postoperative
Corneal edema
Transient 0 (0) 2 (11.2) 0.49
Persistent 1 (5.9)† 0 (0) 0.49
Vitreous prolapse into the anterior 
chamber and IOL decentration 0 (0) 1 (5.6) 1.00
Posterior capsule opacity 2 (11.8)‡ 1 (5.6)‡ 0.60
Persistently elevated IOP 2 (11.8) 0 (0) 0.23
*Data presented as n (%); †one patient in group 1 with previous corneal grafting and
band keratopathy developed persistent corneal edema and graft failure 2 years later
and received another corneal transplant; ‡two patients in group 1 and one patient 
in group 2 developed posterior capsule opacity within 3 months, for which Nd:YAG
capsulotomy was performed. IOL = intraocular lens; IOP = intraocular pressure.
with absolute glaucoma. There were no other in-
traoperative complications in either of the groups,
specifically no zonular rupture, posterior capsule
rupture, vitreous loss, or IOL displacement.
Postoperatively, persistent corneal edema was
only seen in one eye. This patient in group 1 pre-
viously had corneal grafting, and underwent cor-
neal regrafting 2 years later. On the other hand,
mild and transient corneal edema was observed
in two eyes in group 2 at 1 week postoperatively,
but this resolved completely within 1 month after
phacoemulsification. One eye in group 2 had a
small amount of vitreous prolapse into the ante-
rior chamber and mild IOL decentration postop-
eratively but vision was not impaired. Posterior
capsule opacity was noted in two eyes in group 1
and one eye in group 2 during the 3-month 
follow-up period, but Nd:YAG capsulotomy led
to improvement in visual acuity in all three of
these eyes. Persistently elevated intraocular pres-
sure (IOP) was noted in two eyes in group 1.
Preoperatively, one of these eyes had phacolytic
uveitis with absolute glaucoma and the other had
neovascular glaucoma caused by central retinal
vein occlusion.
Figure 3 shows the final visual acuity of pa-
tients in groups 1 and 2 as a function of their ini-
tial visual acuity. Final visual acuity was improved
(at least two lines) in 11 (64.7%) of 17 eyes in
group 1 and was unchanged in the other six eyes
(35.3%). The six eyes that had no improvement in
visual acuity postoperatively had advanced ptery-
gium (one eye), band keratopathy (one eye), ab-
solute glaucoma (one eye), central retinal vein
occlusion (one eye), or myopic maculopathy (two
eyes). On the other hand, all eyes in group 2 had
improved visual acuity (at least two lines) after the
operation (p < 0.01).
Y.S. Chang, et al
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Figure 2. Intraoperative appearance of a complicated advanced cataract after instillation of 0.5% indocyanine green to
distinguish the anterior capsule from the underlying white cortex. (A) Immediately after a cystotome had been used to
create a small flap-tear of the anterior capsule at the start of capsulorhexis, two radial tears developed spontaneously,
from the flap to the periphery, because of high intralenticular pressure. (B) A semicircular capsulorhexis incision was
made starting at the peripheral end of each tear, resulting in two semicircular capsulorhexis flaps separated by two radial
relaxing incisions.
Im
pr
ov
ed
Un
ch
an
ge
d
W
or
se
20/20
20/25
20/40
20/60
20/200
CF
HM
LP
NLP
20
/2
0
20
/2
5
20
/4
0
20
/6
0
20
/2
00CFHML
P
NL
P
Initial (preoperative) visual acuity
Group 2
Group 1
Fi
na
l (
po
st
op
er
at
iv
e)
 v
is
ua
l a
cu
ity
Figure 3. Visual acuity improvement (postoperative as a
function of preoperative) after phacoemulsification of ad-
vanced cataract in 17 eyes with anterior segment abnor-
malities (group 1) and 18 eyes without (group 2).
Table 5 shows the distribution of final visual
acuity in the two groups of patients. Phacoemul-
sification of complicated advanced cataract re-
sulted in significantly less favorable outcome with
regards to visual acuity than that of simple ad-
vanced cataract (p < 0.01).
Discussion
Since the introduction of dye-enhanced capsu-
lorhexis several years ago, CCC in eyes with ad-
vanced cataracts is no longer an insurmountable
challenge for surgeons.5–20 Furthermore, in cases
of complicated or simple advanced cataracts, in-
stilling ICG to enhance visualization of the cap-
sule margin is safe and effective.
Effectiveness and complications of 
dye-assisted phacoemulsification in 
simple advanced cataracts
Two characteristics of advanced cataracts pose
challenges for phacoemulsification: the lack of a
red reflex to identify the capsule margin during
CCC and emulsification of a hard nucleus. A vari-
ety of techniques to better visualize the capsular
margin have been reported, including dimming
the room lights,23 increasing optical magnifica-
tion of the operating microscope,23 side illumi-
nation with an endoilluminator,24 injection of an
air bubble into the anterior chamber,25 two-step
CCC,3,4,26 using a high-frequency diathermy probe
and high-density viscoelastic agent,27 creating a
reverse triangular capsulotomy,28 and aspiration
of the cortical material in liquefied cataract,4 he-
mocoloration of the capsule with autologous
blood,8,29 and dye-enhanced techniques, including
subcapsular or intracameral injection of fluorescein
sodium (FS), ICG, TB or gentian violet (GV).5–20
The most successful of these methods is the dye-
enhanced method, and results of studies using
these methods are summarized in Table 6.
With the two-step CCC method, the rate of
success was 72–95%, and in the study with the
higher success rate, the rate of intraoperative com-
plications was 25% (residual cortical debris) to
60% (raised intracapsular pressure), and rates of
postoperative complications were 5–20% (Table
6).3 Reported success rates in studies of dye-
enhanced CCC are 94–100% for ICG, 96–100%
for TB, 80–100% for FS (only two of five studies
reported the CCC success rate), and 100% for
two studies of GV (Table 6). The greatest experi-
ence with dye-enhanced CCC has been reported
for TB (a total of 182 eyes) and ICG (a total of
143 eyes, including the 18 eyes in the present
study) (Table 6). In addition to its clinical safety,
TB has been shown to be safe and effective for
enhancement of visualization of CCC in a rabbit
model.21,22 Furthermore, in our clinical experience
(unpublished data), TB works as well as ICG for
CCC during phacoemulsification of simple ad-
vanced cataracts. In our patients with simple 
advanced cataracts (group 2), ICG-assisted pha-
coemulsification was as successful and safe as dye-
assisted phacoemulsification reported by others
(Table 6).5,7–11,13–15,19,20
Effectiveness and complications of 
dye-assisted phacoemulsification in
complicated advanced cataracts
To date, only a limited number of reports have
been published regarding the use of dye to assist
in CCC for phacoemulsification of complicated
advanced cataracts. Bhartiya et al30 have used TB
0.1% to assist in phacoemulsification of cataracts
in 11 eyes with nebulomacular corneal opacities.
Use of TB facilitated completion of CCC in all
cases, although in one case, phacoemulsification
had to be converted to extracapsular cataract ex-
traction because of intraoperative haze. In another
series of patients, Baykara et al found that using
ICG for advanced cataracts
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Table 5. Final visual acuity after phacoemulsification of advanced
cataract in 17 eyes with anterior segment abnormalities
(group 1) and 18 eyes without (group 2)*
Final visual acuity Group 1 Group 2 p
Good (20/40–20/20) 6 (35.3) 14 (77.8) 0.006
Moderate (20/100–20/50) 2 (11.8) 3 (16.7)
Poor (20/200 or less) 9 (52.9) 1 (5.6)
*Data presented as n (%).
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0.1% TB to stain the anterior capsule facilitated
successful capsulorhexis in 10 patients with trau-
matic swollen lens due to perforating eye injuries.31
Kobayashi et al have used 0.5% ICG successfully
in four cases undergoing a triple procedure; the
dye was applied to the anterior capsule after trephi-
nation and facilitated successful CCC in all four
cases.32
In the present study of ICG-assisted pha-
coemulsification in 17 patients with advanced
cataracts, complicated by a variety of anterior
segment abnormalities, ICG was as safe and ef-
fective for CCC as in previous studies of TB or
ICG used for complicated advanced cataracts.30–32
In our experience, use of dye is almost required
to achieve a perfect CCC and uneventful phaco-
emulsification of advanced cataracts in eyes with
anterior segment abnormalities such as corneal
opacity, small pupil, or glaucoma.
Comparison of dye-assisted
phacoemulsification for complicated 
versus simple advanced cataracts
With regard to ethics and the difficulty of perform-
ing phacoemulsification in eyes with advanced
cataracts complicated by anterior segment abnor-
malities, we chose to compare the use of dye in
patients with simple versus complicated advanced
cataracts, rather than comparing use or no use of
dye in patients with complicated advanced cata-
racts. Although our results showed that applying
ICG dye to the anterior capsule was safe in all
cases of advanced cataract and very helpful in CCC
for phacoemulsification of advanced cataracts in
eyes with co-existing anterior segment abnormal-
ities, great caution should be exercised during all
stages of surgery in these latter cases.
Except for the presence of anterior segment
abnormality, the only significant difference pre-
operatively between group 1 and group 2 patients
in this study was age (Table 1). This difference is
explained by the fact that simple advanced cata-
racts are more frequently seen in older patients,
whereas complicated advanced cataracts may oc-
cur in patients of any age who have an underly-
ing ocular or systemic disease. The age difference
between the two groups may have resulted in a
bias toward being over-conservative for the main
outcomes, such as intraoperative/postoperative
complications and final visual acuity.
One significant difference between groups 1
and 2 in our study was that an iris hook was
needed to extend the pupil in five (29.4%) eyes
with complicated advanced cataract, but not in
any of the eyes with simple advanced cataract.
However, the proportion of eyes in each group
that required a bare sclera technique or removal
of calcium plaque was similar (Table 3).
As shown in Table 4, groups 1 and 2 also dif-
fered in the rate of radial tear, which occurred in
four (23.5%) eyes in group 1 versus none in
group 2. Radial tear was most often caused by the
lens being swollen and was not related to the use
of dye. To decrease the risk of radial tear, Gimbel
advocated a two-stage CCC or aspiration of the
milky cortex before CCC.26 If only one radial tear
occurs, capsulorhexis can be continued after mak-
ing a snip cut to create a new flap. Similarly, if a
large horizontal tear occurs and extends to the
periphery on both sides, two semicircular CCCs
can be created, as shown in Figure 2. However,
phacoemulsification must be performed with ex-
treme caution to prevent extension of the tear to
the posterior capsule, and the IOL should be
placed in the sulcus with the haptics oriented at
90 degrees to the radial tear, especially when
complicated by posterior capsular rupture.
With regard to postoperative complications,
groups 1 and 2 did not differ significantly (Table
4), and none of the complications was related to
the use of ICG. Transient corneal edema occurred
in two eyes in group 2 after phacoemulsification
of simple advanced cataract. The edema in these
cases might have been caused by high phaco
power, prolonged time to complete phacoemul-
sification, and/or extended manipulation of the
hard lens. Except for persistent corneal edema
(delayed corneal decompensation) that occurred
in an eye with previous corneal graft, our series
showed that ICG did not induce significant cor-
neal endothelial injury, macular edema, or other
retinal injuries. Postoperative vitreous prolapse
and IOL decentration that occurred in one eye in
group 2 might have been caused by subclinical
or iatrogenic zonular dehiscence. Early develop-
ment of posterior capsule opacity (two eyes in
group 1 and one in group 2) might have resulted
from hidden residual lens fibers. The persistent
elevation of IOP in two eyes in group 1 was 
related to pre-existing glaucoma.
The differences between groups 1 and 2 in
improvement in postoperative visual acuity were
related to limitations in improvement in group 1
caused by the nature of pre-existing ocular condi-
tions. In addition, age difference between groups
may have influenced our results. If older age was
related to a worse surgical condition or progno-
sis, the outcome in the simple advanced cataract
group would have been intrinsically worse than
that in the complicated advanced cataract group.
This might reduce the significant level we can
observe for our main outcomes, including intra-
operative or postoperative complications, and final
visual acuity. Our results showed a statistical sig-
nificance in the rate of intraoperative radial tear
and in the final visual acuity but no difference in
the rate of postoperative complications. If patient
age in the two groups was matched, the rate of
postoperative complications might become more
statistically different. A future study with matched
demographic features will be able to eliminate
such a confounding factor and bias in the results.
Choice of dye for dye-assisted
phacoemulsification
As shown in Table 6, clinical studies have been
conducted on four dyes (ICG, TB, FS, GV) to assist
with phacoemulsification. Our previous study has
investigated various concentrations of these dyes
and methylene blue (MB) in a rabbit model21 and
no cytotoxic effects were observed after 1 minute
exposure to 0.25% ICG, 0.20% MB, 0.01% GV,
0.40% TB, or 10% FS, whereas cytotoxicity was
observed after 1 minute of exposure to 0.50%
ICG, 0.50% MB, or 0.10% GV. Furthermore, the
lowest effective concentration for anterior capsule
staining was 0.25% ICG, 0.10% MB, 0.01% GV,
0.10% TB and 1.25% FS.22 Pandey et al reported
that, in postmortem eyes, the staining quality pro-
vided by 0.5% ICG was slightly superior to that
provided by 0.1% TB or 2% FS.23 In a recent clin-
ical study that compared different dyes for phaco-
emulsification of white cataracts,8 0.1% TB, 0.5%
ICG and 0.001% GV were more effective in stain-
ing the anterior capsule than 2% FS or autol-
ogous blood. In another comparative study,9 the
staining provided by 0.1% TB was reported to be
slightly superior to that provided by 0.5% ICG.
The concentration of ICG generally used for
cataract surgery is 0.5%,5–10 which raises a clini-
cal concern of corneal endothelial toxicity. In the
limited number of relevant studies to date,
Horiguchi et al5 and Chung et al10 reported no
significant difference in corneal endothelial cell
counts between patients with or without use of
ICG in capsulorhexis. Although we found that
0.5% ICG damaged rabbit cultured corneal en-
dothelial cells within 1 minute of exposure,21 this
result can not be directly extrapolated to clinical
practice. Theoretically, corneal endothelial cells
in vivo should be more resistant than cultured cells
for four reasons. First, the amount of ICG used is
limited. Second, the duration of exposure clini-
cally is generally less than 1 minute. Third, direct
contact of ICG with the corneal endothelium is
prevented by an air bubble. Fourth, the proteins
and buffered ions in the aqueous humor offer
some protection against the toxic effects of ICG.
The case numbers in our study were limited;
therefore, we recommend larger-scale clinical trials
and quantitative measurement of corneal endo-
thelial counts by specular microscopy to compare
the efficacy and safety of various dyes for pha-
coemulsification of advanced cataracts.
The present study, believed to be the first to
investigate the feasibility of ICG-assisted phaco-
emulsification in eyes with complicated or sim-
ple advanced cataracts, showed that staining the
anterior capsule with 0.5% ICG facilitates visual-
ization of the capsule during phacoemulsification,
particularly when there is an anterior segment
abnormality such as corneal opacity, small pupil,
or glaucoma, and is not associated with any ad-
verse effects. Although patients with complicated
Y.S. Chang, et al
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advanced cataracts had a higher incidence of radial
tear of the anterior capsule and less improvement
of final visual acuity, these differences resulted
from underlying causes of complicated advanced
cataracts, and were not related to ICG use.
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